BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26535588)

  • 41. Renal impairment in HIV-infected patients initiating tenofovir-containing antiretroviral therapy regimens in a Primary Healthcare Setting in South Africa.
    Kamkuemah M; Kaplan R; Bekker LG; Little F; Myer L
    Trop Med Int Health; 2015 Apr; 20(4):518-26. PubMed ID: 25442109
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Determinants and Incidence of Chronic Kidney Disease with Tenofovir- Based Antiretroviral Therapy Regimens: A Cohort Study in HIV-Infected Adults in South China.
    Liu F; Wang Y; Liu H; Chen C; Miao LB; Li ZY; Wang MC; Huang JS; Bao JF
    Curr HIV Res; 2022; 20(3):242-250. PubMed ID: 36111752
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of Tenofovor Diproxil Fumarate on Renal Function and Urinalysis Abnormalities in HIV-Infected Cameroonian Adults.
    Fritzsche C; Rudolph J; Huenten-Kirsch B; Hemmer CJ; Tekoh R; Kuwoh PB; Glass A; Reisinger EC
    Am J Trop Med Hyg; 2017 Nov; 97(5):1445-1450. PubMed ID: 29140230
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term renal effects of tenofovir-disoproxil-fumarate in vertically HIV-infected children, adolescents, and young adults: a 132-month follow-up study.
    Giacomet V; Nannini P; Vigano A; Erba P; Benincaso A; Bedogni G; Cattaneo D; Falvella FS; Zuccotti GV
    Clin Drug Investig; 2015 Jul; 35(7):419-26. PubMed ID: 26013475
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic model for nephrotoxicity among HIV-positive Zambian adults receiving tenofovir disoproxil fumarate-based antiretroviral therapy.
    Chabala FW; Siew ED; Mutale W; Mulenga L; Mweemba A; Goma F; Banda N; Kaonga P; Wester WC; Heimburger DC; Aliyu MH; Munkombwe D
    PLoS One; 2021; 16(7):e0252768. PubMed ID: 34252117
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tenofovir is associated with increased tubular proteinuria and asymptomatic renal tubular dysfunction in Ghana.
    Chadwick DR; Sarfo FS; Kirk ES; Owusu D; Bedu-Addo G; Parris V; Owusu AL; Phillips R
    BMC Nephrol; 2015 Dec; 16():195. PubMed ID: 26627687
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safety and efficacy of coformulated efavirenz/emtricitabine/tenofovir single-tablet regimen in treatment-naive patients infected with HIV-1.
    Gallien S; Flandre P; Nguyen N; De Castro N; Molina JM; Delaugerre C
    J Med Virol; 2015 Feb; 87(2):187-91. PubMed ID: 25070158
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tenofovir-induced renal tubular dysfunction in vertically HIV-infected patients associated with polymorphisms in ABCC2, ABCC4 and ABCC10 genes.
    Giacomet V; Cattaneo D; Viganò A; Nannini P; Manfredini V; Ramponi G; Clementi E; Zuccotti GV
    Pediatr Infect Dis J; 2013 Oct; 32(10):e403-5. PubMed ID: 24067562
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tenofovir use is associated with a reduction in calculated glomerular filtration rates in the Swiss HIV Cohort Study.
    Fux CA; Simcock M; Wolbers M; Bucher HC; Hirschel B; Opravil M; Vernazza P; Cavassini M; Bernasconi E; Elzi L; Furrer H;
    Antivir Ther; 2007; 12(8):1165-73. PubMed ID: 18240857
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Switching from tenofovir containing regimens to boosted protease inhibitor monotherapy: Impact on renal function.
    Estébanez M; Bernardino JI; Serrano L; Pérez-Valero I; Zamora FX; Montes-Ramírez ML; González-García JJ; Arribas JR
    Enferm Infecc Microbiol Clin; 2016 Jan; 34(1):29-32. PubMed ID: 25735716
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tenofovir exposure alters associations of serum bicarbonate with chronic kidney disease risk in HIV-infected veterans.
    Kim JE; Scherzer R; Estrella MM; Ix JH; Shlipak MG
    AIDS; 2016 Apr; 30(7):1049-57. PubMed ID: 26760455
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Renal function of MDR-TB patients treated with kanamycin regimens or concomitantly with antiretroviral agents.
    Sagwa EL; Ruswa N; Mavhunga F; Rennie T; Mengistu A; Mekonen TT; Leufkens HGM; Mantel-Teeuwisse AK
    Int J Tuberc Lung Dis; 2017 Dec; 21(12):1245-1250. PubMed ID: 29297444
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Progressive renal tubular dysfunction associated with long-term use of tenofovir DF.
    Kinai E; Hanabusa H
    AIDS Res Hum Retroviruses; 2009 Apr; 25(4):387-94. PubMed ID: 19361280
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prospective Study to Assess Progression of Renal Markers after Interruption of Tenofovir due to Nephrotoxicity.
    Bonjoch A; Echeverría P; Perez-Alvarez N; Puig J; Estany C; Clotet B; Negredo E
    Biomed Res Int; 2016; 2016():4380845. PubMed ID: 28078289
    [No Abstract]   [Full Text] [Related]  

  • 55. Proximal renal tubular dysfunction related to antiretroviral therapy among HIV-infected patients in an HIV clinic in Mexico.
    Andrade-Fuentes K; Mata-Marín JA; López-De León JI; Manjarrez-Téllez B; Ramírez JL; Gaytan-Martínez J
    AIDS Patient Care STDS; 2015 Apr; 29(4):181-5. PubMed ID: 25101526
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Temporal changes in renal glomerular function associated with the use of Tenofovir Disoproxil Fumarate in HIV-infected Nigerians.
    Agbaji OO; Agaba PA; Idoko JA; Taiwo B; Murphy R; Kanki P; Ekong E
    West Afr J Med; 2011; 30(3):164-8. PubMed ID: 22120479
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High prevalence of signs of renal damage despite normal renal function in a cohort of HIV-infected patients: evaluation of associated factors.
    Bonjoch A; Juega J; Puig J; Pérez-Alvarez N; Aiestarán A; Echeverría P; Pérez V; Clotet B; Romero R; Bonet J; Negredo E
    AIDS Patient Care STDS; 2014 Oct; 28(10):524-9. PubMed ID: 25238104
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tenofovir-induced nephrotoxicity: A retrospective cohort study.
    Koh HM; Suresh K
    Med J Malaysia; 2016 Dec; 71(6):308-312. PubMed ID: 28087953
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tenofovir-Associated Nephrotoxicity in Children with Perinatally-Acquired HIV Infection: A Single-Centre Cohort Study.
    Lim Y; Lyall H; Foster C
    Clin Drug Investig; 2015 May; 35(5):327-33. PubMed ID: 25861908
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The impact of tenofovir disoproxil fumarate on kidney function: four-year data from the HIV-infected outpatient cohort.
    Monteiro N; Branco M; Peres S; Borges F; Mansinho K
    J Int AIDS Soc; 2014; 17(4 Suppl 3):19565. PubMed ID: 25394072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.